Association of polymorphism in adiponectin (+45 T/G) and leptin (-2548 G/A) genes with type 2 diabetes mellitus in male Egyptians

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorMotawi T.
dc.contributor.authorSalman T.
dc.contributor.authorShaker O.
dc.contributor.authorAbdelhamid A.
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherCairo University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Faculty of Pharmacy
dc.contributor.otherAl Azhar University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Faculty of Medicine
dc.contributor.otherCairo University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Faculty of Pharmacy
dc.contributor.otherMSA University
dc.contributor.otherGiza
dc.contributor.other201
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:42:02Z
dc.date.available2020-01-09T20:42:02Z
dc.date.issued2015
dc.descriptionScopus
dc.description.abstractIntroduction: Adiponectin is an adipose tissue-specific protein with insulin- sensitizing properties. Many investigators have explored the association between adiponectin single nucleotide polymorphisms (SNPs) and type 2 diabetes mellitus (T2DM) in different ethnic populations from different regions. Leptin is a protein hormone constituting an important signal in the regulation of adipose tissue mass and body weight. The aim of this study was to explore potential associations between SNP +45 T>G of the adiponectin gene and SNP 2548G/A of leptin with T2DM and the effect of SNPs on serum adiponectin and leptin levels. Material and methods: From the Egyptian population, we enrolled 110 T2DM patients and 90 non-diabetic controls. Serum lipid profile, blood glucose, serum adiponectin, and leptin were measured. Genotyping for two common SNPs of the adiponectin and leptin genes was performed by polymerase chain reaction-restriction fragment length polymorphism. Results: The G allele and TG/GG genotype of SNP 45 occurred more frequently than the T allele and TT genotype in T2DM patients compares to the controls. Subjects with the GG + TG genotype of SNP 45 were at increased risk for T2DM (OR = 6.476; 95% CI: 3.401-12.33) and associated with a low serum adiponectin level compared with the TT genotype. The serum leptin concentration of GA + AA genotype carriers was not significantly different from that of the GG genotype in the diabetic group. Conclusions: The G allele carriers who have reduced plasma concentrations of adiponectin may have an association with T2DM, while leptin SNP 2548 G/A is not associated with the risk of development of T2DM in the Egyptian population. Copyright 2015 Termedia & Banach.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=4000151806&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.5114/aoms.2015.54848
dc.identifier.doiPubMed ID :
dc.identifier.issn17341922
dc.identifier.otherhttps://doi.org/10.5114/aoms.2015.54848
dc.identifier.otherPubMed ID :
dc.identifier.urihttps://t.ly/gdlL6
dc.language.isoEnglishen_US
dc.publisherTermedia Publishing House Ltd.en_US
dc.relation.ispartofseriesArchives of Medical Science
dc.relation.ispartofseries11
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectUniversity for Modern Sciences and Arts
dc.subjectMSA University
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectPolymerase chain reaction-restriction fragment length polymorphismen_US
dc.subjectSingle nucleotide polymorphismen_US
dc.subjectadiponectinen_US
dc.subjectglucoseen_US
dc.subjectleptinen_US
dc.subjectlipiden_US
dc.subjectadulten_US
dc.subjectalleleen_US
dc.subjectArticleen_US
dc.subjectcontrolled studyen_US
dc.subjectdiabetic patienten_US
dc.subjectEgyptianen_US
dc.subjectgenetic associationen_US
dc.subjectgenotypeen_US
dc.subjectglucose blood levelen_US
dc.subjecthumanen_US
dc.subjectlipid blood levelen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectnon insulin dependent diabetes mellitusen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectprotein blood levelen_US
dc.subjectrestriction fragment length polymorphismen_US
dc.subjectrisk assessmenten_US
dc.subjectsingle nucleotide polymorphismen_US
dc.titleAssociation of polymorphism in adiponectin (+45 T/G) and leptin (-2548 G/A) genes with type 2 diabetes mellitus in male Egyptiansen_US
dc.typeArticleen_US
dcterms.isReferencedBy(2011) Top 10 Countries in Prevalence of Diabetes, , www.worlddiabetesday.org/files/docs/top_10_countries.pdf, International Diabetes Federation. approached; Guerre-Millo, M., Adipose tissue and adipokines: For better or worse (2004) Diabetes Metab, 30, pp. 13-19; Kukla, M., Berdowska, A., Gabriel, A., Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients (2011) Pol J Pathol, 62, pp. 218-228; Mori, Y., Otabe, S., Dina, C., Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p (2002) Diabetes, 51, pp. 1247-1255; Gable, D.R., Hurel, S.J., Humphries, S.E., Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease (2006) Atherosclerosis, 188, pp. 231-244; Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., Tobe, K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome (2006) J Clin Invest, 116, pp. 1784-1792; Mohammadzadeh, G., Zarghami, N., Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals (2009) J Sci Clin Lab Invest, 15, pp. 1-8; Maury, E., Brichard, S., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome (2010) Mol Cell Endocrinol, 314, pp. 1-16; Martin, S.S., Qasim, A., Reilly, M.P., Leptin resistance: A possible interface of inflammation and metabolism in obesity-related cardiovascular disease (2008) J Am Coll Cardiol, 52, pp. 1201-1210; Van Der Lende, T., Te Pas, M.F., Veerkamp, R.F., Liefers, S.C., Leptin gene polymorphisms and their phenotypic associations (2005) Vitam Horm, 71, pp. 373-404; Strobel, A., Issad, T., Camoin, L., A leptin missense mutation associated with hypogonadism and morbid obesity (1998) Nat Genet, 18, pp. 213-215; Chagnon, Y.C., Wilmore, J.H., Borecki, I.B., Associations between the leptin receptor gene and adiposity in middle-Aged Caucasian males from the HERITAGE family study (2000) J Clin Endocrinol Metab, 85, pp. 29-34; Matsuoka, N., Ogawa, Y., Hosoda, K., Human leptin receptor gene in obese Japanese subjects: Evidence against either obesity-causing mutations or association of sequence variants with obesity (1997) Diabetologia, 40, pp. 1204-1210; Trinder, P., Determination of glucose in blood using an oxidase-peroxidase system with a non-carcinogenic chromogen (1969) J Clin Pathol, 22, pp. 158-161; Richmond, W., Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum (1973) Clin Chem, 19, pp. 1350-1356; Siedel, J., Hagele, E.O., Ziegenhorn, J., Wahlefeld, A.W., Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency (1983) Clin Chem, 29, pp. 1075-1080; Burstein, M., Scholnick, H.R., Morfin, R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions (1970) J Lipid Res, 11, pp. 583-595; Hatch, F.T., Lees, R.S., Practical methods for plasma lipoprotein analysis (1968) Adv Lipid Res, 6, pp. 1-68; Cleeman, J.I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) (2001) JAMA, 285, pp. 2486-2497; Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man (1985) Diabetologia, 28, pp. 412-419; Lee, Y.Y., Lee, N.S., Cho, Y.M., Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population (2004) Diabet Med, 22, pp. 569-575; Petridou, E., Mantzoros, C.S., Belechri, M., Neonatal leptin levels are strongly associated with female gender, birth length, IGF-I levels and formula feeding (2005) Clin Endocrinol (Oxf), 62, pp. 366-371; Chilton, R., Wyatt, J., Nandish, S., Oliveros, R., Lujan, M., Cardiovascular comorbidities of type 2 diabetes mellitus: Defining the potential of glucagon like peptide-1-based therapies (2011) Am J Med, 124, pp. 35-53; Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes (2006) Nature, 444, pp. 840-846; Gordon, L., Ragoobirsingh, D., St Errol, Y.A., Choo-Kang, E., Mc-Growder, D., Martorell, E., Lipid profile of type 2 diabetic and hypertensive patients in the Jamaican population (2010) J Lab Physic, 2, pp. 25-30; Wilson, P.W., D'Agostino, R.B., Parise, H., Sullivan, L., Meigs, J.B., Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus (2005) Circulation, 112, pp. 3066-3072; Yamauchi, T., Kamon, J., Waki, H., Replenishment of the fat-derrived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (2001) Nat Med, 7, pp. 941-946; Fruebis, J., Tsao, T.S., Javorschi, S., Proteolytic cleavage product of 30-kDa adipocyte complement related protein increases fatty acid oxidation in muscle and causes weight loss in mice (2001) Proc Natl Acad Sci, 98, pp. 2005-2010; Mohammadzadeh, G., Zarghami, N., Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals (2009) Scand J Clin Labor Investig, 69, pp. 764-771; Hara, K., Boutin, P., Mori, Y., Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population (2002) Diabetes, 51, pp. 536-540; Li, L.L., Kang, X.L., Ran, X.J., Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes (2007) Clin Exp Pharmacol Physiol, 34, pp. 1287-1290; Morandi, A., Maffeis, C., Lobbens, S., Early detrimental metabolic outcomes of rs17300539-A Allele of ADIPOQgene despite higher adiponectinemia (2010) Obesity, 18, pp. 1469-1473; Vasseur, F., Helbecque, N., Dina, C., Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians (2002) Hum Mol Genet, 11, pp. 2607-2614; Lee, Y., Lee, N., Cho, Y., Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population (2005) Diabet Med, 22, pp. 569-575; Gonzalez-Sanchez, J.L., Zabena, C.A., Martinez-Larrad, M.T., An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance (2005) Obes Res, 13, pp. 807-812; Zacharova, J., Chiasson, J., Laakso, M., The common polymorphisms (Single Nucleotide Polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial (2005) Diabetes, 54, pp. 893-899; Anagnostis, P., Vakalopoulou, S., Charizopoulou, M., Is there any association between leptin levels and bone mineral density in haemophiliac men? (2013) Arch Med Sci, 9, pp. 459-465; J�quier, E., Leptin signaling, adiposity, and energy balance (2002) Ann N Y Acad Sci, 967, pp. 379-388; Wauters, M., Considine, R.V., Yudkin, J.S., Peiffer, F., De Leeuw, I., Van Gaal, L.F., Leptin levels in type 2 diabetes: Associations with measures of insulin resistance and insulin secretion (2003) Horm Metab Res, 35, pp. 92-96; Gong, D., Bi, S., Pratley, R., Weintraub, B., Genomic structure and promoter analysis of the human obese gene (1996) J Biol Chem, 271, pp. 3971-3974; Hoffstedt, J., Eriksson, P., Mottagui-Tabar, S., Arner, P., A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin (2002) Horm Metab Res, 34, pp. 355-359; Wang, T.N., Huang, M.C., Chang, W.T., G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines (2006) Obesity, 14, pp. 183-187; Duarte, S., Francischetti, E.A., Genelhu, V.A., Cabello, P.H., Pimentel, M.M.G., LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects (2007) Genet Mol Res, 6, pp. 1035-1043; Hinuy, H.M., Hirata, M.H., Forti, N., Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women (2008) Arq Bras Endocrinol, 52, pp. 611-616; Matsuoka, N., Ogawa, Y., Hosoda, K., Human leptin receptor gene in obese Japanese subjects: Evidence against either obesity-causing mutations or association of sequence variants with obesity (1997) Diabetologia, 40, pp. 1204-1210; Wauters, M., Mertens, I., Chagnon, M., Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women (2001) Int J Obes Relat Metab Disord, 25, pp. 714-720; Heo, M., Leibel, R.L., Fontaine, K.R., A meta-Analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference (2002) Int J Obes Relat Metab Disord, 26, pp. 640-646; Mergen, H., Karaaslan, C., Mergen, M., DenizOzsoy, E., Ozata, M., LEPR ADBR3 IRS-1 and 5-HTT genes polymorphisms do not associate with obesity (2007) Endocr J, 54, pp. 89-94; Cummings, D.E., Schwartz, M.W., Genetic and pathophysiology of human obesity (2003) Annu Rev Med, 54, pp. 453-471; Gong, D.W., Bi, S., Pratley, R.E., Genomic structure and promoter analysis of the human obese gene (1996) J Biol Chem, 271, pp. 3971-3974; Mammes, O., Betoulle, D., Aubert, R., Novel polymorphisms in the 5' region of the LEP gene association with leptin levels and response to low-calorie diet in human obesity (1998) Diabetes, 47, pp. 487-489
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
AMS-11-25964.pdf
Size:
101.11 KB
Format:
Adobe Portable Document Format
Description: